ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Clinical Cooperative Groups Funding To Decrease 42.5 Mil.

October 11, 1985

In Brief: USC Norris Opens Topping Tower March 21; Postal Service To Sell Breast Cancer Stamps

March 15, 1996